Validity and Reliability of the CarGOQoL Questionnaire Among Informal Caregivers of Patients With Cancer by Eun Ko PhD, Hye Young Kim PhD, Woo Kyun Bae PhD, Jun-Eul Hwang PhD

Get full text

Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction by Seung Hyuk Lee, Hyeon Jong Kim, Hyun Jin Bang, Su Ji Park, Ji Eun Yu, Seung Woo Jeong, Woo Kyun Bae

Get full text

Dynamic changes in immune cells in humanized liver metastasis and subcutaneous xenograft mouse models by Hyun Jin Bang, Kyung-Hwa Lee, Myong Suk Park, Eun-Gene Sun, Sang Hee Cho, Ik-Joo Chung, Hyun-Jeong Shim, Woo Kyun Bae

Get full text

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer by Manh-Cuong Vo, Van-Tan Nguyen, Van-Dinh-Huan Tran, Hyung-Joo Oh, Sung-Hoon Jung, Woo Kyun Bae, Je-Jung Lee, In-Jae Oh

Get full text

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis by Hyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, Hyun Jin Bang, Sang Hee Cho, Ik-Joo Chung, Eu Chang Hwang, Jun Eul Hwang, Woo Kyun Bae

Get full text

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis by Eun-Gene Sun, Veena Vijayan, Mi-Ra Park, Kyung Hyun Yoo, Sang-Hee Cho, Woo-Kyun Bae, Hyun-Jeong Shim, Jun-Eul Hwang, In-Kyu Park, Ik-Joo Chung

Get full text

Galectin 3‐binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor‐β1 (TGF‐β1) availability and inhibits hepatocarcinogenesis... by Dae‐Hwan Kim, Minjeong Sung, Myong‐Suk Park, Eun‐Gene Sun, Sumin Yoon, Kyung Hyun Yoo, Kamalakannan Radhakrishnan, Sung Yun Jung, Woo‐Kyun Bae, Sang‐Hee Cho, Ik‐Joo Chung

Get full text

Prognostic value of the endothelial activation and stress index in patients with upper tract urothelial cancer undergoing radical nephroureterectomy by Jin Seok Gu, Ji Won Ryu, Seong Hyeon Yu, Ho Seok Chung, Jun Eul Hwang, Woo Kyun Bae, Ja Yoon Ku, Chan Ho Lee, Hong Koo Ha, Seung Il Jung, Eu Chang Hwang, Dong Deuk Kwon

Get full text

Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation by Gil-Woo Lee, Young Ju Kim, Sung-Woo Lee, Hee-Ok Kim, Daeun Kim, Jiyoung Kim, You-Me Kim, Keunsoo Kang, Joon Haeng Rhee, Ik Joo Chung, Woo Kyun Bae, In-Jae Oh, Deok Hwan Yang, Jae-Ho Cho

Get full text

613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06... by Jae Ho Byun, Jeeyun Lee, Kyong Hwa Park, Eun Joo Kang, In Gyu Hwang, Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, Jason K Sa, Sook Ryun Park, Yu Kim, Woo Kyun Bae, Jung Sun Kim, Sang Shin

Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer by Sung-Woo Lee, Ju Sik Yun, Hyun-Ju Cho, In-Jae Oh, Deok Hwan Yang, Jae-Ho Cho, Eu Chang Hwang, Young Ju Kim, Woo Kyun Bae, Saei Jeong, Jeong Eun Noh, Kyung Na Rho, Hee-Ok Kim, Sook Jung Yun, Cheol-Kyu Park

Get full text

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06) by Jae Ho Byun, Jeeyun Lee, Kyong Hwa Park, Eun Joo Kang, Sang Joon Shin, In Gyu Hwang, Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, Jason K Sa, Sook Ryun Park, Jung Sun Kim, Yu Jung Kim, Woo Kyun Bae, Won Jin Chang, Eun-Ok Kim

Get full text

Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy by Sung‐Woo Lee, Young Ju Kim, Saei Jeong, Kyung Na Rho, Jeong Eun Noh, Hee‐Ok Kim, Hyun‐Ju Cho, Yoo Duk Choi, Deok Hwan Yang, Eu Chang Hwang, Woo Kyun Bae, Sook Jung Yun, Ju Sik Yun, Cheol‐Kyu Park, In‐Jae Oh, Jae‐Ho Cho

Get full text

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer by Choong-kun Lee, Sun Young Rha, Hyo Song Kim, Minkyu Jung, Beodeul Kang, Jingmin Che, Woo Sun Kwon, Sejung Park, Woo Kyun Bae, Dong-Hoe Koo, Su-Jin Shin, Hyunki Kim, Hei-Cheul Jeung, Dae Young Zang, Sang Kil Lee, Chung Mo Nam, Hyun Cheol Chung

Get full text

Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals by Jae-Hoon Ko, Choon-Mee Kim, Mi-Seon Bang, Da-Yeon Lee, Da-Young Kim, Jun-Won Seo, Na-Ra Yun, Jin-Young Yang, Kyong-Ran Peck, Kyo-Won Lee, Sung-Hoon Jung, Hyun-Jin Bang, Woo-Kyun Bae, Tae-Jong Kim, Kyeong-Hwan Byeon, Sung-Han Kim, Dong-Min Kim

Get full text

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries by Choong-kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, David Wai Meng Tai, Hyeyeong Kim, Krittiya Korphaisarn, Suebpong Tanasanvimon, San-Chi Chen, Ju Won Kim, Ilhwan Kim, Moonho Kim, Joan Choo, Sang-Bo Oh, Ching-Tso Chen, Woo Kyun Bae, Hongsik Kim, Seok Jae Huh, Chia-Jui Yen, Sejung Park, Dong Ki Lee, Landon Long Chan, Beodeul Kang, Minsu Kang, Raghav Sundar, Hye Jin Choi, Stephen Lam Chan, Hong Jae Chon, Myung-Ah Lee

Get full text